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Abstract The crystal structure of human transaldolase has been
determined to 2.45 Aî resolution. The enzyme folds into an K/L
barrel structure and is thus similar in structure to other class I
aldolases. Structure-based sequence alignment of available
sequences of the transaldolase subfamily reveals that eight active
site residues are invariant in the whole subfamily. Other invariant
residues are mainly involved in the formation of the hydrophobic
core of the enzyme. Noteworthy is a hydrophobic cluster
consisting of five invariant residues. Human transaldolase has
been implicated as an autoantigen in multiple sclerosis and four
immunodominant peptide segments are located at the surface of
the enzyme, accessible to autoantibodies. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Transaldolase (EC 2.2.1.2), one of the enzymes in the non-
oxidative branch of the pentose phosphate pathway, catalyzes
the reversible transfer of a dihydroxyacetone moiety from
fructose 6-phosphate to erythrose 4-phosphate, giving sedo-
heptulose 7-phosphate and glyceraldehyde 3-phosphate. The
reaction mechanism includes formation of a Schi¡ base inter-
mediate by an active site lysine [1,2], a characteristic of class I
aldolases [3]. Amino acid sequence comparisons suggest that
transaldolases can be divided into two subclasses: the trans-
aldolase and the MipB/TalC subfamilies. Most enzymes of the
transaldolase subfamily consist of around 320^350 amino
acids per polypeptide chain. The crystal structure analysis of
Escherichia coli transaldolase, a representative of this subfam-
ily, revealed that these enzymes contain an eight-stranded K/L
barrel fold and that they are related to other class I aldolases
by a circular permutation [4,5]. This permutation of the trans-
aldolase gene shifts the catalytic lysine residue from the clas-
sical position in L-strand 6 in class I aldolases to L-strand 4 of
the K/L barrel.
Multiple sclerosis (MS) is considered an autoimmune dis-
ease of the central nervous system resulting in chronic in£am-
mation. Human transaldolase has been implicated as an auto-
antigen in this process based on detection of T-cell
autoreactivity and autoantibodies in the serum and cerebro-
spinal £uid of MS patients [6^8]. These ¢ndings prompted us
to initiate genetic, biochemical [9,10] and structural studies
with the aim of characterizing the human enzyme in more
detail. Here, we report the three-dimensional structure of hu-
man transaldolase at 2.45 Aî resolution.
2. Materials and methods
2.1. Protein puri¢cation and crystallization
Human transaldolase was produced in E. coli and puri¢ed as de-
scribed previously [10]. Crystals were obtained by the hanging drop
method using a mother liquid consisting of 27% (w/v) PEG4000,
0.08% NaN3, 0.3 M NH4Ac, pH 4.4. For crystallization, 3 Wl of a
protein solution (6 mg/ml in 50 mM Tris, pH 7.0) was mixed with an
equal amount of mother liquid and the droplets were then left to
equilibrate with 1 ml of the mother solution at 20‡C. Crystals of
about 0.1 mm in length grew within 24 h.
2.2. Data collection and structure solution
Di¡raction data (Table 1) were collected at 100 K to 2.45 Aî reso-
lution at beamline 711, MAX Laboratory, University of Lund, using
a £ash-frozen crystal soaked in 20% ethylene glycol as cryoprotectant.
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Table 1
Data collection and re¢nement statistics
Data collection :
Space group P21
Cell dimensions (Aî ) a = 45.6, b = 113.6, c = 69.2,
L= 101.4‡








Resolutiona (Aî ) 20^2.45 (2.60^2.45)
Number of re£ections
Total 22 371
working set 21 230
test set 1 141
Number of residues 322U2




Deviations from ideal (rmsd)
bond distances (Aî ) 0.006
bond angles (‡) 1.2
dihedrals (‡) 20.6
impropers (‡) 0.80
B values (Aî 2)
protein (all atoms) 21.4
solvent 16.2
Ramachandran plot
% non-glycine or non-proline
residues
in most favored regions 92.8
additional allowed regions 6.8
generously allowed regions 0.3
disallowed regions 0.0
aValues in parentheses are for the highest resolution shell.
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The X-ray data were processed and merged with the programs DEN-
ZO [11] and SCALA [12]. Cell dimensions and space group (Table 1)
were determined by the auto-indexing routine in DENZO and by
manual inspection of simulated precession images using the program
PATTERN [13]. Self-rotation functions indicated the presence of a
local two-fold axis suggesting a dimer in the crystal asymmetric unit,
consistent with a VM value of 2.37 Aî 3/Da.
The structure was determined by molecular replacement using the
program AMORE [14] and the coordinates for transaldolase from E.
coli [4] as search model. In a ¢rst run, the orientation and position of
one of the two subunits in the asymmetric unit was found and kept
¢xed when searching for the second molecule. Both rotation and
translation searches were calculated with data in the resolution inter-
val 20.0^4.0 Aî with an integration radius of 30 Aî . The search using
one subunit gave two solutions with a correlation coe⁄cient 0.458 and
an R value of 0.483. After inclusion of the second molecule these
values changed to 0.614 and 0.415, respectively.
2.3. Model building and re¢nement
After initial rigid body re¢nement using the program REFMAC
[15] the side chains were exchanged for their proper counterparts [9]
in the human enzyme. Further re¢nement was performed in the inter-
val 24^2.45 Aî with the program CNS [16] followed by manual adjust-
ments after each re¢nement cycle using the programs O [17] and Oops
[18]. Tight non-crystallographic symmetry restraints were imposed,
except for residues 11^12, 45^47, 51^53, 69^79, 123, 202^206, 230,
265, 276^285, 325 and 332. In these cases the electron density maps
indicated deviations from the two-fold symmetry. In the re¢nement
the parameters described by Engh and Huber [19] were used. The
quality of the model was checked with the program PROCHECK
[20]. Detailed statistics of re¢nement and model are listed in Table
1. The observed structure factor amplitudes and the atomic coordi-
nates have been deposited with the Protein Data Bank, accession code
1fo5.
3. Results and discussion
3.1. Structure determination and electron density maps
In the electron density maps, the polypeptide chain is well
de¢ned except for 10 residues at the N-terminus and ¢ve res-
idues at the C-terminus. The quality of the electron density
map was very good for the A chain, while the B chain showed
a few regions with weak electron density. In both chains, res-
idue Ser-237 is found in the generously allowed region of the
Ramachandran plot. This residue is well de¢ned in electron
Fig. 1. Conservation of amino acid sequence in the transaldolase
subfamily. The sequence of human transaldolase is shown together
with the secondary structural elements. Invariant residues are shown
in red, while residues in green are more than 90% conserved. Active
site residues are marked by * and # denotes residues participating
in the dimer interface. The available 22 full-length amino acid se-
quences for members of the transaldolase subfamily were aligned us-
ing ClustalW (http://www2.ebi.ac.uk/clustalw).
Fig. 2. Schematic view of the transaldolase monomer. The four
most immunodominant peptide stretches in MS patients are shown
in red and residue numbers are given. The side chains participating
in the invariant hydrophobic cluster are shown in magenta. The ¢g-
ure was generated with Bobscript [24] and Raster3d [25].
Fig. 3. Superposition of the CK traces of human (gray) and E. coli (black) transaldolase. The labels indicate the peptide segments which di¡er
most in structure between the two enzymes. The ¢gure was generated using the programs Bobscript [24] and Raster3d [25].
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density in both chains and is also located in the same P,i
region in E. coli transaldolase.
3.2. Overall structure
Human transaldolase consists of a single domain of 337
amino acids. The core structure is an eight-stranded K/L barrel
made up of eight parallel L-strands (L1^L8) and seven K-heli-
ces (K2^K8). There are seven additional K-helices (KA^KG)
(Figs. 1 and 2).
In the crystal, human transaldolase forms a dimer and the
interface covers an area of 1700 Aî 2 corresponding to 7% of
the total accessible surface area in the dimer. Contributing to
the subunit^subunit interface are 18 residues from the A chain
and their symmetry mates in the B chain. Most of these res-
idues are located in helices KG, KF and the loop connecting
these helices. The remaining residues are found in the loop
between L3 and K3 and at the N-terminus of helix K4 (Fig. 1).
3.3. Comparison between E. coli and human transaldolase
The structures of E. coli and human transaldolase were
compared using the lsq option in the program O with default
parameters [17], giving a rms (root mean square) deviation of
0.71 Aî for 309 equivalent CK atoms. A stereo view of the
superposed CK traces is shown in Fig. 3. The peptide seg-
ments which di¡er most in structure in the two enzymes are
residues 159^160 in the loop between K4 and L5 and residues
277^288 including KE (276^280) which is a loop in the E. coli
enzyme. Some of the di¡erences could be due to crystal pack-
ing, since residues 159^160 and 285^288 are engaged in inter-
molecular lattice contacts.
The core structure of human transaldolase di¡ers from the
E. coli counterpart in the number of K-helices in the K/L
barrel. The K/L barrel of the human enzyme consists of eight
L-strands and seven K-helices (helix K1 missing) while in the
E. coli enzyme there is a complete barrel with eight L-strands
and eight K-helices. There is also an additional helix, KE (Fig.
1), in the human enzyme, which corresponds to a loop in the
E. coli enzyme. The subunit^subunit interactions and the
dimer interface are highly conserved in the two enzymes.
Out of the 18 residues found in the interface between the
two subunits of E. coli transaldolase, nine are conserved in
the human enzyme. We note, however, that none of these
residues is invariant in all known sequences and only one
residue, Arg-110, is more than 80% conserved in the trans-
aldolase subfamily.
3.4. Invariant residues in the transaldolase subfamily
Amino acid sequence alignment indicates that the transal-
dolase family can be subdivided into two subfamilies. The
‘classical’ transaldolase subfamily is represented by human
and E. coli transaldolase, and is the only subclass with a
known 3D structure. Transaldolases from plants and some
cyanobacteria, having large insertions/deletions at several po-
sitions, might also belong to this subclass. A more divergent
subfamily, MipB/TalC, is represented by prokaryotic enzymes
with a signi¢cantly shorter polypeptide chain of approxi-
mately 200 amino acids [21].
Structure-based sequence alignment of the 22 available se-
quences for members of the transaldolase subfamily reveals 20
invariant residues and 10 residues being at least 90% con-
served (Fig. 1 and Table 2). Most of these, 27, are located
in the K/L barrel core structure. These residues contribute to
catalysis, substrate binding and the hydrophobic packing in-
teractions within the K/L barrel. Eight of the invariant resi-
dues, Asp-27, Asn-45, Glu-106, Lys-142, Asn-165, Thr-167,
Ser-187 and Arg-192, are involved in catalysis and substrate
binding and their function is discussed in more detail else-
where [2,4,10,22]. The invariant proline residue at position
46 is probably required to maintain the conformation of
Asn-45, an invariant active site residue that interacts with
the Schi¡ base intermediate through a hydrogen bond [2].
Of the remaining 22 invariant/highly conserved residues in
the subfamily, 16 are hydrophobic amino acids which contrib-
ute to the packing of L-strands of the barrel to surrounding K-
helices. Particularly noteworthy is the invariant hydrophobic
cluster involving residues Leu-168, Phe-170, Phe-189, Gly-311,
Table 2
Location and suggested function of highly conserved (s 90%) and
invariant (bold) residues in the transaldolase subfamily
Residue Location Possible function
Asp-27 L1 at active site, involved in carbon^carbon
bond cleavage
Thr-43 L2 close to active site, hydrogen bond to
Asp-27
Asn-45 turn L2^KB at active site, interacts with Schi¡ base
intermediate
Pro-46 turn L2^KB turn at active site, structurally important
for proper position of Asn-45
Ala-52 KB packing restraints, not enough space for
larger side chain
Gly-101 loop K2^L3 turn at N-terminal end of barrel,
structurally important
Ser-104 L3 close to active site, forms hydrogen bond
to Asn-165
Glu-106 L3 at active site, involved in Schi¡ base
formation; hydrogen bonded to water
Ala-122 K3 intramolecular hydrophobic interactions,
part of conserved hydrophobic cluster
(Ile-141, Ile-162)
Ile-141 L4 intramolecular hydrophobic interactions,
part of hydrophobic cluster (Ala-122,
Ile-162)
Lys-142 L4 at active site, Schi¡ base forming lysine
Thr-146 turn L4^K4 structural, hydrogen bond from side
chain OQ to main chain nitrogen of
Gly-149
Gly-149 K4 space restraints after tight turn following
L4
Ile-162 loop K4^L5 intramolecular hydrophobic interactions,
part of conserved hydrophobic cluster
(Ala-122, Ile-141)
Asn-165 L5 at active site, interacts with Schi¡ base
intermediate
Thr-167 L5 at active site, catalytic residue
Leu-168 L5 part of invariant hydrophobic cluster
Phe-170 loop L5^K5 part of invariant hydrophobic cluster
Ala-181 loop K5^L5 packing at N-terminal end of K/L barrel
Ser-187 L6 at active site, interacts with Schi¡ base
intermediate
Phe-189 loop L6^KD part of invariant hydrophobic cluster
Val-190 loop L6^KD packing of L6 against loop following K7
Arg-192 KD at active site, part of proposed phosphate
binding site
Tyr-224 K6 packing at N-terminal part of K/L barrel
Thr-231 loop K6^L7 packing at N-terminal part of K/L barrel
Leu-247 loop K7^L8 packing of L6 against loop following K7
Pro-257 K8 structurally important, beginning of helix
K8 after tight turn
Gly-311 KG part of invariant hydrophobic cluster
Phe-315 KG part of invariant hydrophobic cluster
Leu-322 KG packing of helix KG against KB
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and Phe-315. This small hydrophobic core is formed at the
packing interface of helix KG and L-strands L5 and L6 (Fig.
2). Another small conserved hydrophobic cluster is found be-
tween helix K3, L4 and the loop close to the beginning of L5.
3.5. Human transaldolase epitopes
A systematic study identi¢ed several peptide sequences in
human transaldolase that were recognized by autoantibodies
from MS patients, in particular the four peptide segments
comprising residues 101^115, 231^245, 271^285 and 311^325
[23]. The location of these immunodominant peptides in the
3D structure of human transaldolase is shown in Fig. 2. These
segments of the polypeptide chain all contain solvent-exposed
residues and are thus accessible to antibodies. Antibodies
binding to the most prominent epitope, residues 271^285,
showed cross-reactivity with Epstein^Barr and herpes simplex
virus type 1 capsid-derived peptides suggesting that molecular
mimicry might be involved in the autoimmune response [23].
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